Cargando…

Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?

Chronic liver diseases (CLDs) are a public health problem, even if frequently they are underdiagnosed. Hepatic steatosis (HS), encountered not only in nonalcoholic fatty liver disease (NAFLD) but also in chronic viral hepatitis, alcoholic liver disease, etc., plays an important role in fibrosis prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sirli, Roxana, Sporea, Ioan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018863/ https://www.ncbi.nlm.nih.gov/pubmed/33834008 http://dx.doi.org/10.1155/2021/6662760

Ejemplares similares

Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience
por: Sporea, Ioan, et al.
Publicado: (2020)

Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A “Real-Life” Cohort Study
por: Popa, Alexandru, et al.
Publicado: (2021)

Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
por: Sirli, Roxana, et al.
Publicado: (2011)

The BISAP score, NLR, CRP, or BUN: Which marker best predicts the outcome of acute pancreatitis?
por: Dancu, Greta Maria, et al.
Publicado: (2021)

Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter
por: Marc, Luciana, et al.
Publicado: (2022)

A Comparative Study of Non-Invasive Methods for Fibrosis Assessment in Chronic HCV Infection
por: Şirli, Roxana, et al.
Publicado: (2010)

Assessing Baveno VI Criteria Using Liver Stiffness Measured with a 2D-Shear Wave Elastography Technique
por: Fofiu, Renata, et al.
Publicado: (2021)

Spleen Stiffness for Predicting Varices Needing Treatment: Comparison between Two Different Elastography Techniques (Point vs. 2D-SWE)
por: Fofiu, Renata, et al.
Publicado: (2021)

Assessment of noninvasive liver stiffness in inactive HBsAg carriers by transient elastography: Fibroscan in inactive HBsAg carriers
por: Sporea, Ioan, et al.
Publicado: (2011)

Kidney Shear Wave Speed Values in Subjects with and without Renal Pathology and Inter-Operator Reproducibility of Acoustic Radiation Force Impulse Elastography (ARFI) - Preliminary Results
por: Bob, Flaviu, et al.
Publicado: (2014)

Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
por: Ferraioli, Giovanna
Publicado: (2021)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
por: Ogino, Yu, et al.
Publicado: (2021)

Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome
por: Vitel, Andrei, et al.
Publicado: (2020)

Opportunistic Colonoscopy Cancer Screening Pays off in Romania—A Single-Centre Study
por: Rațiu, Iulia, et al.
Publicado: (2021)

Transaminase abnormalities and adaptations of the liver lobule manifest at specific cut-offs of steatosis
por: Hall, Andrew, et al.
Publicado: (2017)

Is There a Place for Elastography in the Diagnosis of Hepatocellular Carcinoma?
por: Ghiuchici, Ana-Maria, et al.
Publicado: (2021)

Performance of a Noninvasive Time-Harmonic Elastography Technique for Liver Fibrosis Evaluation Using Vibration Controlled Transient Elastography as Reference Method
por: Moga, Tudor Voicu, et al.
Publicado: (2020)

Usefulness of the Controlled Attenuation Parameter for Detecting Liver Steatosis in Health Checkup Examinees
por: Kim, Ja Kyung, et al.
Publicado: (2015)

Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis
por: Foncea, Camelia Gianina, et al.
Publicado: (2021)

Comparison of Different Nutritional Assessment Tools in Detecting Malnutrition and Sarcopenia among Cirrhotic Patients
por: Topan, Mirabela-Madalina, et al.
Publicado: (2022)

Association between Dietary Habits and Sarcopenia in Patients with Liver Cirrhosis
por: Topan, Mirabela-Madalina, et al.
Publicado: (2023)

Usefulness of Imaging and Biological Tools for the Characterization of Portal Vein Thrombosis in Hepatocellular Carcinoma
por: Burciu, Călin, et al.
Publicado: (2022)

How efficient is acoustic radiation force impulse elastography for the evaluation of liver stiffness?
por: Sporea, Ioan, et al.
Publicado: (2011)

Predictive factors for severe evolution in acute pancreatitis and a new score for predicting a severe outcome
por: Bota, Simona, et al.
Publicado: (2013)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022)

Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis
por: Topan, Mirabela-Madalina, et al.
Publicado: (2021)

A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers
por: Burciu, Călin, et al.
Publicado: (2023)

Fibrosis Predictive Score in Caucasian Patients with Metabolic Syndrome
por: Mare, Ruxandra, et al.
Publicado: (2022)

Dynamic Changes in Liver Stiffness in Patients with Chronic Hepatitis B Undergoing Antiviral Therapy
por: Lazar, Alin, et al.
Publicado: (2022)

Unraveling the Metabolic Changes in Acute Pancreatitis: A Metabolomics-Based Approach for Etiological Differentiation and Acute Biomarker Discovery
por: Dancu, Greta, et al.
Publicado: (2023)

Which Bayley-III cut-off values should be used in different developmental levels?
por: ÇELİK, Pelin, et al.
Publicado: (2020)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
por: Ferraioli, Giovanna, et al.
Publicado: (2017)

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
por: Steinmann, Silja, et al.
Publicado: (2023)

Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis
por: Hsu, Po-Ke, et al.
Publicado: (2021)

The Prevalence of Liver Fibrosis Stages on More than 23,000 Liver Stiffness Measurements by Vibration-Controlled Transient Elastography: A Single Center Study
por: Lazar, Alin, et al.
Publicado: (2023)

A new scoring system for prediction of fibrosis in chronic hepatitis C
por: Bota, Simona, et al.
Publicado: (2011)

Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_143s2044a3m3o5qmam50i7tk4v